In March 2012, the Supreme Court ruled, in Mayo Collaborative Servs. v. Prometheus Labs., Inc., that a patent claim on a method of determining whether a given dose of a particular type of medication was safe and effective was a “law of nature” and thus invalid. In the article, authors patent partner Robert Sachs and associate Jennifer Bush say that the Court's characterization does not withstand critical analysis.

Login

Don’t have an account yet?

Register